Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma

British Journal of Cancer

Volumn 92, Issue 8, 2005, Pages 1382-1387

  Toh, C K ^a   Heng, D ^b   Ong, Y K ^a   Leong, S S ^a   Wee, J ^a   Tan, E H ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b Singapore Health Services   (Singapore)

Author keywords

Metastatic survival; Nasopharyngeal carcinoma; Prognostic factors

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; FLUOROURACIL; GEMCITABINE; HEMOGLOBIN; PACLITAXEL;

ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; BONE METASTASIS; CANCER PALLIATIVE THERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STATISTICAL ANALYSIS;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 18944371329     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602525     Document Type: Article

References (34)

1. Ahmad A, Stefani S (1986) Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients. J Surg Oncol 33: 194-197
2. Al-Sarraf M, LeBlanc M, Giri PGS, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomised intergroup study 0099. J Clin Oncol 16: 1310-1317
3. Altun M, Fandi A, Dupuis O, Cvitkovic E, Kranjina Z, Eschwege F (1995) Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. Int J Radiat Oncol Biol Phys 32: 859-877
4. Au E, Tan EH, Ang PT (1998) Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer. Ann Oncol 9: 327-329
5. Bokemeyer C, Oechsle K, Hartmann JT, Schoffski P, Schleucher N, Metzner B, Schleicher J, Kanz L (2002) Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer. Br J Cancer 87:1066-1071
6. Caro JJ, Salas M, Ward A, Goss G (2001) Anaemia as an independent prognostic factor for survival in patients with cancer: a systematic, quantitative review. Cancer 91: 2214-2221
7. Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M, Ho S, Huang DP, Johnson PJ (2002) Plama Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 94: 1614-1619
8. Chan AT, Teo ML, Lee WY, Kwan WH, Choi PH, Johnson PJ (1998) The significance of keratinising squamous cell histology in Chinese patients with nasopharyngeal carcinoma. Clin Oncol (R Coll Radial) 10: 161-164
9. Chan ATC, Teo PML, Leung TWT, Johnson PJ (1997) The role of chemotherapy in management of nasopharyngeal carcinoma. Cancer 82: 1003-1012
10. Chia KS, Seow A, Lee H P, Shanmugaratnam K (2000) Cancer incidence in Singapore 1993-1997: Singapore Cancer Registry Report No. 5
11. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS (2001) Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345: 1877-1882
12. Chua DT, Nicholls JM, Sham JS, Au GK (2004) Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 59: 11-20
13. Fandi A, Altun M, Azli N, Armand JP, Cvitkovic E (1994) Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin oncol 21: 382-397
14. Fandi A, Bachouchi M, Azli N, Taamma A, Boussen H, Wibault P, Eschwege F, Armand JP, Simon J, Cvitkovic E (2000) Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J Clin Oncol 18: 1324-1330
15. Hong RL, Sheen TS, Ko JY, Hsu MM, Wang CC, Ting LL (1999) Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study. Br J Cancer 80: 1962-1967
16. Hsiao JR, Jin YT, Tsai ST, Shiau AL, Wu CL, Su WC (2003) Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlate with better prognosis. Br J Cancer 89: 344-349
17. Hsu CH, Chen CL, Hong RL, Chen KL, Lin JF, Cheng AL (2002) Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy. Oncology 62: 305-312
18. Lee AW, Lau WH, Tung SY, Chua D, Chappell R, Siu L, Chia S, Lau J, Law SCK (2004) Prospective randomised study on therapeutic gain achieved by addition of chemotherapy for T1-4N2-3M0 nasopharyngeal carcinoma (NPC). J Clin Oncol 22: 489 (suppl; abstr. 5506)
19. Lee AWM, Poon YF, Foo W, Law SCK, Cheung FK, Chan DKK, Tung SY, Thaw M, Ho JHC (1992) Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Phys 23: 261-270
20. Lin J, Jan J, Hsu C, Liang W, Jiang R, Wang W (2003) Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 21: 631-637
21. Ma BBY, Leungm SF, Hui EP, Mo F, Kwan WH, Zee B, Yuen J, Chan ATC (2004) Prospective validation of serum CYFRA 21-1, β-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy. Cancer 101: 776-781
22. Markman M, Rothman R, Hakes T, Reichman B, Hoskins W, Rubin S, Jones W, Almadrones L, Lewis Jr JL (1991) Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol 9: 389-393
23. Micheau C, Boussen H, Klijanienko J, Cvitkovic E, Stosic S, Schwabb G, Eschwege F, Armand JP (1987) Bone marrow biopsies in patients with undifferentiated carcinoma of the nasopharyngeal type. Cancer 60: 2459-2464
24. Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, Mazumdar M (2004) Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 22: 454-463
25. Obermair A, Cheuk R, Horwood K, Janda M, Bachtiary B, Schwanzelberger B, Stoiber A, Nicklin JL, Perrin LC, Crandon AJ (2001) Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results. Cancer 92: 903-908
26. Ong YK, Heng DM, Chung B, Leong SS, Wee J, Fong KW, Tan T, Tan EH (2003) Design of a prognostic index score for metastatic nasopharyngeal carcinoma. Eur J Cancer 39: 1535-1541
27. Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis G, Thiriaux J, Michel J, Van Cutsem O, Sergysels R, Mommen P (1995) Prognostic factors for survival in advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1052 patients. J Clin Oncol 13: 1221-1230
28. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543,
29. Erratum in: Lancet Oncol 2: 596.
30. Polee MB, Hop WCJ, Kok TC, Eskens FALM, van der Burg MEL, Splinter TAW, Siersema PD, Tilanus HW, Stoter G, van der Gaast A (2003) Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer 89: 2045-2050
31. Reddy SP, Raslan WF, Gooneratne S, Kathuria S, Marks JE (1995) Prognostic significance of keratinisation in nasopharyngeal carcinoma. Am J Otolaryngol 16: 103-108
32. Shanmugaratnam K, Sobin LH (1993) The World Health Organisation histological classification of tumours of the upper respiratory tract and ear. Cancer 71: 2689-2697
33. Teo PM, Kwan WH, Lee WY, Leung SF, Johnson PJ (1996) Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 77: 2423-2431
34. Wee J, Tan EH, Tai BC, wong BH, Leong SS, Tan T, Chua ET, Lee KM, Yang E, Machin D (2004) Phase III randomised trial of radiotherapy versus concurrent chemo-radiotherapy in patients with AJCC/UICC (1997) stage 3 and 4 nasopharyngeal cancer of the endemic variety. J Clin Oncol 22: 488 (suppl; abstr. 5500)